0001907056-26-000006.txt : 20260204 0001907056-26-000006.hdr.sgml : 20260204 20260204161324 ACCESSION NUMBER: 0001907056-26-000006 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20260203 FILED AS OF DATE: 20260204 DATE AS OF CHANGE: 20260204 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Okupe Oluyemi CENTRAL INDEX KEY: 0001907056 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38986 FILM NUMBER: 26598348 MAIL ADDRESS: STREET 1: 2269 CHESTNUT ST., #523 CITY: SAN FRANCISCO STATE: CA ZIP: 94123 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Hims & Hers Health, Inc. CENTRAL INDEX KEY: 0001773751 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2269 CHESTNUT ST STREET 2: #523 CITY: SAN FRANCISCO STATE: CA ZIP: 94123 BUSINESS PHONE: 415-851-0195 MAIL ADDRESS: STREET 1: 2269 CHESTNUT ST STREET 2: #523 CITY: SAN FRANCISCO STATE: CA ZIP: 94123 FORMER COMPANY: FORMER CONFORMED NAME: Oaktree Acquisition Corp. DATE OF NAME CHANGE: 20190412 4 1 wk-form4_1770239598.xml FORM 4 X0508 4 2026-02-03 0 0001773751 Hims & Hers Health, Inc. HIMS 0001907056 Okupe Oluyemi 2269 CHESTNUT STREET, #523 SAN FRANCISCO CA 94123 0 1 0 0 Chief Financial Officer 1 Class A Common Stock 2026-02-03 4 M 0 5262 5.01 A 96879 D Class A Common Stock 2026-02-03 4 S 0 5262 26.4363 D 91617 D Class A Common Stock 7853 I Held by Oluyemi Okupe Separate Property Trust dtd 9-1-2021 Stock Option (right to buy) 5.01 2026-02-03 4 M 0 5262 0 D 2032-02-23 Class A Common Stock 5262 144051 D The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $26.35-$26.56. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. The Reporting Person received stock options to purchase shares of Class A Common Stock. The stock options vest over a 4-year period, with 1/48 of the shares vesting when the Reporting Person completes each month of continuous service, beginning March 24, 2022. /s/ Kimberly Mather, Attorney-in-Fact for Oluyemi Okupe 2026-02-04